CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-29 | ZERBE ROBERT L MD Director | Option exercise | +3,200 | 32,995 | ||
| 2026-04-29 | ZERBE ROBERT L MD Director | Option exercise · Restricted Stock Unit | +3,200 | 0 | ||
| 2026-04-29 | ZERBE ROBERT L MD Director | Grant or award · Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2026-04-29 | ZERBE ROBERT L MD Director | Grant or award · Restricted Stock Unit | +3,200 | 3,200 | ||
| 2026-04-29 | Rubino Alan L Director | Option exercise | +3,200 | 64,194 | ||
| 2026-04-29 | Rubino Alan L Director | Option exercise · Restricted Stock Unit | +3,200 | 0 | ||
| 2026-04-29 | Rubino Alan L Director | Grant or award · Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2026-04-29 | Rubino Alan L Director | Grant or award · Restricted Stock Unit | +3,200 | 3,200 | ||
| 2026-04-29 | WRIGHT LISA Director | Option exercise | +3,200 | 15,851 | ||
| 2026-04-29 | WRIGHT LISA Director | Option exercise · Restricted Stock Unit | +3,200 | 0 | ||
| 2026-04-29 | WRIGHT LISA Director | Grant or award · Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2026-04-29 | WRIGHT LISA Director | Grant or award · Restricted Stock Unit | +3,200 | 3,200 | ||
| 2026-04-02 | Hopper Jonathan Mark Chief Medical Officer | Option exercise 10b5-1 | +3,472 | $10.95 | $38K | 79,028 |
| 2026-04-02 | Hopper Jonathan Mark Chief Medical Officer | Sale 10b5-1 | −3,472 | $35.00 | $122K | 75,556 |
| 2026-04-02 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +3,472 | 9,132 | ||
| 2026-03-25 | Rubino Alan L Director | Option exercise | +15,000 | $2.76 | $41K | 60,994 |
| 2026-03-25 | Rubino Alan L Director | Option exercise · Stock Option (Right to Buy) | +15,000 | 0 | ||
| 2026-03-23 | Hagen Heidi Director | Option exercise 10b5-1 | +15,000 | $2.76 | $41K | 46,850 |
| 2026-03-23 | Hagen Heidi Director | Sale 10b5-1 | −15,000 | $32.41 | $486K | 31,850 |
| 2026-03-23 | Hagen Heidi Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | +15,000 | 0 |
Page 6 of 75 · 1,497 trades